Identification and quantitative analysis of beta-galactoside-alpha-2,6 sialotransferase 1 (ST6Gal1), a potential impurity in the PB007 Ustekinumab project, using high-resolution LC-ESI-Q-TOF-MS mass spectrometry.

Description

Identification and quantitative analysis of beta-galactoside-alpha-2,6 sialotransferase 1 (ST6Gal1), a potential impurity in the PB007 Ustekinumab project, using high-resolution LC-ESI-Q-TOF-MS mass spectrometry.

Tomasz K. Goździewicz, Polpharma Biologics S.A.

Resources

Name Format Description Link
8 https://dane.gov.pl/pl/dataset/3579/resource/54351
8 https://dane.gov.pl/pl/dataset/3579/resource/54349
8 https://dane.gov.pl/pl/dataset/3579/resource/54350

Tags

  • ustekinumab
  • lek-biopodobny
  • profil-bezpieczeństwa
  • innowacyjna-formulacja
  • linia-komórkowa

Topics

  • HEAL
  • TECH

Categories